Clinical Trial: A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor

U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07275242) titled 'A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor' on Nov. 27.

Brief Summary: The study is being conducted to evaluate the pharmacokinetics , safety, tolerability and efficacy in patients with solid tumor.

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Solid Tumor

Intervention: DRUG: SHR-A1811 Subcutaneous Injection

SHR-A1811 subcutaneous injection.

DRUG: SHR-A1811 for Injection

SHR-A1811 for injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Published by HT Digital Content Services with permission from Health Dai...